英傑電氣(300820.SZ):目前產品已成功應用於多個國家級核聚變項目
格隆匯6月3日丨英傑電氣(300820.SZ)在互動平臺表示,可控核聚變作爲未來能源的重要發展方向,在技術突破與政策支持下,行業前景廣闊。依託多年電源技術積累,公司爲國內科研院所的核聚變重點項目,提供涵蓋 PSM 電源、直流高壓電源等在內的全方位關鍵電源配套服務,目前產品已成功應用於多個國家級核聚變項目。當前,公司正積極跟進多個重要核聚變項目的商業合作,憑藉技術、經驗與資源優勢,提前佈局商業化場景。隨着核聚變技術商業化進程加速,公司將努力憑藉深厚技術積澱與市場先機,提升在行業內的市場份額,實現該行業的業務增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.